Ready to play
Ready to play
A team of scientists from Cairo University, in collaboration with other Egyptian institutions, has developed an innovative nanoparticle treatment to combat vaginal fungal infections caused by Candida albicans. These infections can recur and develop resistance to traditional therapies. The treatment relies on a hybrid technique that combines the repeated use of the drug "Atorvastatin" with nanotechnology, integrating it into a nano-system that enhances the delivery of the active substance to the infected tissues and amplifies its effect. Laboratory experiments have shown that the gel formulation successfully eradicated 100% of the fungal colonies and reduced inflammation without tissue irritation, opening new horizons for alternative treatments for resistant cases. However, clinical studies are needed to confirm safety and efficacy before widespread use.
Notice: This Is an AI-Generated Summary
Comments (0)